ATC code M04

ATCcodeM04Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. ^{[1] [2] [3]} Subgroup M04 is part of the anatomical group M Musculo-skeletal system. ^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04. ^[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M04A Antigout preparations

M04AA Preparations inhibiting uric acid production

M04AA01 Allopurinol

M04AA02 Tisopurine

M04AA03 Febuxostat

M04AA51 Allopurinol, combinations

M04AB Preparations increasing uric acid excretion

M04AB01 Probenecid

M04AB02 Sulfinpyrazone

M04AB03 Benzbromarone

M04AB04 Isobromindione

M04AB05 Lesinurad

M04AB06 Dotinurad

M04AC Preparations with no effect on uric acid metabolism

M04AC01 Colchicine

M04AC02 Cinchophen

M04AC51 Colchicine and probenecid

M04AX Other antigout preparations

M04AX01 Urate oxidase

M04AX02 Pegloticase

References

1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health . Retrieved 1 February 2020.
2. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization . Retrieved 3 January 2022.
3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
4. "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
5. "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.